Skip to content

Evidence-Driven Differential Diagnosis of Malignant Melanoma

Aug 2026 · ISIC/Care-AI/MedAGI/DeCaF@MICCAI · pp. 57-66 · 4 citations · 26 references
Computer Science Engineering

TL;DR

An anatomic-site aware masked transformer is introduced, which effectively models the patient context by considering all lesions in a patient by considering all lesions in a patient, which can be variable in count, and their site of incidence.

Abstract

We present a modular and multi-level framework for the differential diagnosis of malignant melanoma. Our framework integrates contextual information and evidence at the lesion, patient, and population levels, enabling decision-making at each level. We introduce an anatomic-site aware masked transformer, which effectively models the patient context by considering all lesions in a patient, which can be variable in count, and their site of incidence. Additionally, we incorporate patient metadata via learnable demographics embeddings to capture population statistics. Through extensive experiments, we explore the influence of specific information on the decision-making process and examine the tradeoff in metrics when considering different types of information. Validation results using the SIIM-ISIC 2020 dataset indicate including the lesion context with location and metadata improves specificity by 17.15% and 7.14%, respectively, while enhancing balanced accuracy. The code is available at https://github.com/narenakash/meldd.

View source

Similar papers

Open access 2026

Towards Transparent Decisions: CNN Ensemble with XAI-Driven Interpretations

A comprehensive deep learning-based framework that leverages three benchmark datasets—PH2, ISIC (Benign vs Malignant), and HAM10000—using transfer learning and ensemble techniques is presented, demonstrating a notable increase in classification accuracy.

A. D. Hayder, J. Saeed · 0 citations
Aug 2026

MulGM-Net: A decision-based gated memory network with contrastive learning for multi-task cancer diagnosis

Experiments on two datasets suggest the potential utility of MulGM-Net for joint tumor delineation and malignancy assessment in head-and-neck and breast imaging, while the limited dataset size and the absence of external validation indicate that broader confirmation is still required.

Xin Jin, Jie Wang, Yun Ge et al. · 0 citations
Conference Sep 2026

Trustworthy AI for Skin Cancer Image Classification

Skin cancer constitutes a growing global health burden, with melanoma representing one of its highly aggressive and potentially lethal subtypes. Dermoscopy enhances early diagnosis by improving the visualisation of lesion structures. However, interpretation remains subjective and dependent on clinical expertise. Deep l...

Anusha Augustine, I. Al-Dhamari, J. Jürjens et al. · 0 citations
Open access Sep 2026

The Impact of Bias Mitigation on Fairness and Accuracy in Automated Skin Lesion Classification

To the best of our knowledge, existing benchmarks for bias mitigation in skin cancer classification focus exclusively on image-based, leaving a gap in the tabular-multimodal setting, where image-derived probabilities are combined with structured clinical data. To address this gap, this paper proposes an experimental...

M. B. Rocha, R. Krohling · 0 citations
Open access 2026

A Hierarchical Lesion-Conditioned Cross-Attention Network for Multimodal Breast Cancer Classification

Existing multimodal approaches for breast cancer classification rely on fixed-stage fusion, where clinical features are incorporated as static auxiliary inputs, limiting dynamic interactions between visual and clinical information. Furthermore, reported performance gains in this literature are rarely validated under le...

Deema A. Alzamil, B. Alkhamees · 0 citations

Related blog posts

MIT News · Artificial Intelligence Sep 29, 2026

Who we become when we talk to machines

Professor Sherry Turkle’s new book, “Artificial Intimacy,” offers a withering critique of chatbots and the antisocial dynamics she believes they encourage.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.